Lumbar Calcifying Pseudoneoplasm as a Rare Cause of Cauda Equina Syndrome: A Case Report

Article information

Nerve. 2023;9(1):56-59
Publication date (electronic) : 2023 April 20
doi : https://doi.org/10.21129/nerve.2022.00255
1Department of Neurosurgery, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy
2Department of Neurosurgery, Neurosurgery Clinic, Birgunj, Nepal
Corresponding author: Bipin Chaurasia Department of Neurosurgery, Neurosurgery Clinic, Birgunj, Birta 33400, Nepal Tel: +977-9845454636 Fax: +977-9845454636 E-mail: trozexa@gmail.com
Received 2022 December 18; Revised 2023 February 3; Accepted 2023 February 13.

Abstract

A calcifying pseudo-tumor of the spine, also called calcifying pseudoneoplasm of the neuraxis (CAPNON), is a rare non-neoplastic lesion that can occur anywhere in the central nervous system. Although CAPNON shows tumor-like behavior, it is believed to be benign and of inflammatory-reactive origin. It may cause many neurologic symptoms by compressing adjacent structures. We report the case of a 45-year-old man who presented with cauda equina syndrome. Magnetic resonance imaging revealed a partially calcified mass compressing the spinal cord. Gross total resection was carried out and the patient’s symptoms improved. Histopathology proved that the mass was CAPNON. Although spinal localization of CAPNON is rare, we should know and recognize this entity based on appropriate imaging findings because radical excision has an excellent prognosis.

INTRODUCTION

Calcifying fibrous pseudoneoplasm, also known as calcifying pseudoneoplasm of the neuraxis (CAPNON) when found in the central nervous system, are rare pathological entities that are benign non- neoplastic fibrous lesions1,9,10,19). It’s usually found in patients who are above 50 years and, in some cases, is associated with neurofibromatosis type 24,5,14). The disease may be found in the peritoneum, neck, mediastinum, breast, extremities, central nervous system, and spinal cord11,12). When the spine is involved, its most frequently located in cervical region followed by thoracic and lumber areas. CAPNON may be both intra- and extra-dural16). Pathogenesis of CAPNON is still unclear, however, it is thought of as reactive lesions with abundant hyalinized collagenous fibrous tissue with psammomatous or dystrophic calcification and focal lymphoplasmacytic infiltrate3,7,13).

Patients who are diagnosed with CAPNON can have a variety of symptoms from no symptoms at all to myelopathies, depending on the location and compression of the surrounding neural structure9,15). Therefore, the management of CAPNON is largely dependent on the symptoms, and when patients show severe neurologic deficits, complete surgical removal is the treatment of choice18). Since CAPNON has excellent treatment outcomes when successfully removed, a thorough diagnostic screening needs to be carried out. Magnetic resonance imaging (MRI) is the modality of choice of investigation which shows hypo intense T1- and T2-weighted images with limited edema and contrast enhancement13,16,17).

We present a rare case of CAPNON in the lumbosacral region showing cauda equine syndrome, mimicking hourglass neurinoma or ependymoma.

CASE REPORT

A 45-year-old man came to the hospital emergency room (ER) with severe low back pain and motor weakness in both low extremities for 5 days (motor grade 3). Neurologic examination revealed altered sensations in his buttocks, inner thighs, backs of legs and feet, typically demonstrating saddle-like paresthesia in L5-S1 dermatome. He had also altered bowel and bladder habits prior to the visit to the ER. His overall symptoms suggested the possibility of cauda equina syndrome which could lead to a possible emergency operation and thus, was admitted to our neurosurgery department for further diagnostic evaluations.

MRI showed an intradural mass extending into the neural foramen where signals revealed partial calcification at the L5-S1 disc level (Fig. 1A, B). Surgical removal was carried out via laminectomy of L5 lamina to achieve clear access to intradural calcified lesions. The dura was incised vertically just above the mass. The incision was then extended just above and below the lesion to get a clear view of the tumor. The tumor was resting on the posterior dura, adhered with the fibers of S1 within the neural foramen.

Fig. 1.

(A) Preoperative sagittal T1-weighted magnetic resonance imaging (MRI) with gadolinium enhancement displaying the L5-S1 intradural neoplasm. (B) Preoperative axial T1-weighted MRI with gadolinium enhancement displaying the L5-S1 intradural neoplasm.

During surgery, the nerve roots of the dural sac adjacent to the tumor were moved by gentle spatulation with a small dissector. The lesion had a fibrous consistency due to the presence of calcifications. There were no hemorrhagic focus and infiltration into the surrounding tissues. The mass was successfully removed without giving any injury to surrounding neurologic anatomy.

A biopsy was carried out with the mass acquired during surgery. It confirmed the diagnosis of CAPNON. The histopathological slide was stained for hematoxylin and eosin which showed positivity for the expression of factor XIIIa and vimentin and negativity for the expression of CD31, CD34, anaplastic lymphoma kinase (ALK)-1, smooth muscle actin (SMA), protein S100 and VIII factor (Fig. 2A, B).

Fig. 2.

(A) Histological findings include central calcification with surrounding chondroid matrix organized in a nodular pattern. There are palisade spindle cells around the nodules (hematoxylin and eosin stain [H&E], ×100 magnification). (B) Histological findings showing inflammatory cells in the fibrovascular stroma between chondromyxoid cells.

On the first day after surgery the patient showed complete resolution of cauda syndrome. After three months, we performed a follow-up lumbosacral MRI with contrast which showed no recurrence (Fig. 3A, B). After 15 months, patients came for follow-up with no signs and symptoms of any recurrent disease.

Fig. 3.

(A) Postoperative sagittal T1-weighted MRI with gadolinium enhancement displaying no remnant tumor or recurrence. (B) Postoperative axial T1-weighted MRI with gadolinium enhancement displaying no remnant tumor or any recurrence.

DISCUSSION

Calcifying fibrous pseudoneoplams occurring in the neuraxis is very rare. Nevertheless, it is rather more common for it to occur in the spine than in the brain6,7). To the author’s knowledge, there are only 29 similar cases of CAPNON occurring in the spine so far (Table 1). According to previous studies, the tumor has a male preference occurring mostly in patients aging more than fifty and can be present in all levels of the spine3). The characteristics of the tumor also varied greatly from case to case, where it was interosseous, intradural, extradural and even intradural extramedullary8,16).

Reported cases of calcifying pseudoneoplasm of the neuraxis located in the spinal cord

CAPNON can only be diagnosed after a full histopathologic and immunohistochemical analysis4,14,19). It is difficult to suspect and diagnose the disease with only conventional imaging workup such as MRI, computed tomography (CT) scans and X-rays. The tumor usually displays partial calcifications on CT scans and on the MRI it usually shows a well-defined hypointense lesion in T1 and T2 weighted images along with limited hyperintensity after contrast enhancement T1 weighted imaging13,15,20). Due to these non-specific characteristics of the tumor, it is crucial for physicians to rule out other more common possible disease entities. Chondromas, chordomas, meningiomas and schwannomas were considered in the differential diagnosis for extra-axial localizations, while oligodendrogliomas and ganglioglioma for intra-axial localizations3,12).

The typical histopathological characteristics of CAPNON are predominantly lymphoplasmacytic infiltrate with abundant hyalinized collagen, dystrophic calcifications, fibrous stroma with chondromixoid matrix, epithelioid cells arranged in palisades and similar inflammatory reaction with giant cells3,7,16).

There have been some controversies regarding CAPNON being inflammatory or neoplastic. Pathologists had hypothesized that calcifying fibrous pseudotumor, as a slow-growing benign tumor, derived from inflammatory myofibroblastic tumor than from a typically inflammatory lesion3). The anatomopathologists in recent years have hypothesized that calcifying fibrous pseudotumor was true benign tumor entities without having an inflammatory origin because they did not present the characteristic immunohistochemical markers of inflammatory myofibroblastic tumors2,14).

In the case presented in this study it showed similar results where it showed hyalinized leiomyoma (positive for smooth muscle markers, SMA, desmin, negative for the expression of factor XIII); Inflammatory myofibroblastic tumor (negative for SMA expression and only sporadically positive for Keratin and desmin expression, while always positive for the expression of factor XIIIa and ALK).

The overall treatment outcome is known to be excellent with complete surgical removal7). Recurrences appeared rare even after complete or incomplete resection of the disease3,7). Stienen et al.19) found no recurrence of lesion in 92.3% of the cases.

CONCLUSION

CAPNON is a rare but benign tumor now considered an autonomous anatomopathological entity. Neurosurgeons should be aware of the disease and recognize this entity through conventional image workups and histopathologic outcomes because radical excision determines an excellent prognosis.

Notes

No potential conflict of interest relevant to this article was reported.

References

1. Aiken AH, Akgun H, Tihan T, Barbaro N, Glastonbury C. Calcifying pseudoneoplasms of the neuraxis: CT, MR imaging, and histologic features. AJNR Am J Neuroradiol 30:1256–1260. 2009;
2. Bertoni F, Unni KK, Dahlin DC, Beabout JW, Onofrio BM. Calcifying pseudoneoplasms of the neural axis. J Neurosurg 72:42–48. 1990;
3. Chorti A, Papavramidis TS, Michalopoulos A. Calcifying fibrous tumor: Review of 157 patients reported in international literature. Medicine (Baltimore) 95:e3690. 2016;
4. Fetsch JF, Montgomery EA, Meis JM. Calcifying fibrous pseudotumor. Am J Surg Pathol 17:502–508. 1993;
5. García Duque S, Medina Lopez D, Ortiz de Méndivil A, Diamantopoulos Fernández J. Calcifying pseudoneoplasms of the neuraxis: Report on four cases and review of the literature. Clin Neurol Neurosurg 143:116–120. 2016;
6. Gauden AJ, Kavar B, Nair SG. Calcifying pseudoneoplasm of the neuraxis: A case report and review of the literature. J Clin Neurosci 70:257–259. 2019;
7. Hill KA, Gonzalez-Crussi F, Chou PM. Calcifying fibrous pseudotumor versus inflammatory myofibroblastic tumor: a histological and immunohistochemical comparison. Mod Pathol 14:784–790. 2001;
8. Ho ML, Eschbacher KL, Paolini MA, Raghunathan A. New insights into calcifying pseudoneoplasm of the neuraxis (CAPNON): a 20-year radiological-pathological study of 37 cases. Histopathology 76:1055–1069. 2020;
9. Hodges TR, Karikari IO, Nimjee SM, Tibaleka J, Friedman AH, Cummings TJ, et al. Calcifying pseudoneoplasm of the cerebellopontine angle: case report. Neurosurgery 69:onsE117–onsE120. 2011;
10. Kerr EE, Borys E, Bobinski M, Shahlaie K. Posterior fossa calcifying pseudoneoplasm of the central nervous system. J Neurosurg 118:896–902. 2013;
11. Kocovski L, Parasu N, Provias JP, Popovic S. Radiologic and histopathologic features of calcifying pseudoneoplasm of the neural axis. Can Assoc Radiol J 66:108–114. 2015;
12. Liccardo G, Lunardi P, Menniti A, Floris R, Pastore FS, Fraioli B. Calcifying pseudo-tumor of the spine: description of a case and review of the literature. Eur Spine J 12:548–551. 2003;
13. Lopes AJ, Brock RS, Martins TG, de Medeiro RS, Montezzo D, de Oliveira MF, et al. Intradural calcifying pseudoneoplasm of the neuraxis presenting as a cauda equina syndrome. Surg Neurol Int 7:S1102–S1105. 2016;
14. Maeda A, Kawabata K, Kusuzaki K. Rapid recurrence of calcifying fibrous pseudotumor (a case report). Anticancer Res 22:1795–1797. 2002;
15. Mayr MT, Hunter S, Erwood SC, Haid RW. Calcifying pseudoneoplasms of the spine with myelopathy. Report of two cases. J Neurosurg 93:291–293. 2000;
16. Mohapatra I, Manish R, Mahadevan A, Prasad C, Sampath S, Shankar SK. Calcifying pseudoneoplasm (fibro osseous lesion) of neuraxis (CAPNON) - a case report. Clin Neuropathol 29:223–226. 2010;
17. Naidu PK, Patel SC. Calcifying pseudoneoplasm of the neural axis arising within the lumbar spine: Implications of unique cross-sectional imaging characteristics of a rare spinal column lesion. Neurographics 2:27–30. 2012;
18. Nathoo N, Viloria A, Iwenofu OH, Mendel E. Calcifying fibrous tumor of the spine. World Neurosurg 77:592.e1-592.e4. 2012;
19. Stienen MN, Abdulazim A, Gautschi OP, Schneiderhan TM, Hildebrandt G, Lücke S. Calcifying pseudoneoplasms of the neuraxis (CAPNON): clinical features and therapeutic options. Acta Neurochir (Wien) 155:9–17. 2013;
20. Ravi V, Srinath P. A rare case of calcifying pseudoneoplasms of the neural axis in lumbar spine. Indian J Neurosurg 11:177–178. 2021;

Article information Continued

Fig. 1.

(A) Preoperative sagittal T1-weighted magnetic resonance imaging (MRI) with gadolinium enhancement displaying the L5-S1 intradural neoplasm. (B) Preoperative axial T1-weighted MRI with gadolinium enhancement displaying the L5-S1 intradural neoplasm.

Fig. 2.

(A) Histological findings include central calcification with surrounding chondroid matrix organized in a nodular pattern. There are palisade spindle cells around the nodules (hematoxylin and eosin stain [H&E], ×100 magnification). (B) Histological findings showing inflammatory cells in the fibrovascular stroma between chondromyxoid cells.

Fig. 3.

(A) Postoperative sagittal T1-weighted MRI with gadolinium enhancement displaying no remnant tumor or recurrence. (B) Postoperative axial T1-weighted MRI with gadolinium enhancement displaying no remnant tumor or any recurrence.

Table 1.

Reported cases of calcifying pseudoneoplasm of the neuraxis located in the spinal cord

References Year Location of tumor Recurrence Neurologic outcome after surgery
Bertoni et al.2) 1990 Lumbar None Improved
Fetsch et al.4) 1993 Lumbar None Improved
Mayr et al.15) 2000 Cervical and thoracic None Improved
Liccardo et al.12) 2003 Dorsal None Improved
Aiken et al.1) 2009 Dorsal None Not described
Mahapatra et al.16) 2010 Lumber None Improved
Naidu et al.17) 2012 Lumbar None Improved
Nathoo et al.18) 2012 Lumbar None Improved
Stienen et al.19) 2013 Lumber None Improved
Kocovski et al.11) 2015 Lumbar Not described Not described
Lopes et al.13) 2016 Lumbar None Improved
García Duque et al.5) 2016 Cervical, dorsal, and lumbar None Improved
Gauden et al.6) 2019 Cervical None Improved
Ho et al.8) 2020 Cervical, dorsal, and lumbar None Variable
Ravi et al.20) 2022 Lumbar None Improved

The data is presented as number (%) or mean ± standard deviation.

OPLL: ossification of the posterior longitudinal ligament.